La respuesta a darbepoetina-‐alfa…
553
3. KDIGO. Clinical Practice Guideline for Anemia in Chronic Kidney Disease. Kidney Int.
Suppl.
2
, 279-‐335 (2012).
4. Macdougall, IC.; Cooper, AC.;Erythropoietin resistance: the role of inflammation and pro-‐
inflammatory cytokines. Nephrol. Dial. Transplant.
17 (
Suppl 11), 39-‐43 (2002).
5. Mann, J.; Kessler, M.; Villa, G.; Martinez-‐Castelao, A.; Feldt-‐Rasmussen, B.; Cruz, J.; et al.
Darbepoetin alfa once every 2 weeks for treatment of anemia in dialysis patients: a
combined analysis of eight multicenter trials. Clin. Nephrol.
67
,140-‐48 (2007).
6. Vanrenterghem, Y.; Barany, P; Mann, JF; Kerr, PG; Wilson, J.; Baker, NF.; et al. Randomized
trial of darbepoetin alfa for treatment of renal anemia at a reduced dose frequency
compared with rHuEPO in dialysis patients. Kidney Int.
62
, 2167-‐75 (2002)
7. Locatelli, F.; Aljama, P.; Barany, P.; Canaud, B.; Carrera, F.; Eckardt, KU.; et al. Revised
European best practice guidelines for the management of anaemia in patients with chronic
renal failure. Nephrol. Dial. Transplant.
19
Suppl 2, 1-‐47 (2004).
8. KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for anemia in
chronic kidney disease: 2007 update of hemoglobin target. Am. J. Kidney Dis.
50
, 471-‐530
(2007).
9. Pfeffer, MA.; Burdmann, EA.; Chen, CY.; Cooper, ME.;De, ZD.; Eckardt, KU.; et al. A trial of
darbepoetin alfa in type 2 diabetes and chronic kidney disease. N. Engl. J. Med.
19
,2019-‐
2032 (2009).
10. Szczech, LA.; Barnhart, HX.; Sapp, S.; Felker, GM.;Hernandez, A.; Reddan. D.; et al. A
secondary analysis of the CHOIR trial shows that comorbid conditions differentially affect
outcomes during anemia treatment. Kidney Int.
77
, 239-‐246 (2010).
11. Drueke, TB.; Locatelli, F.; Clyne, N.; Eckardt, KU.; Macdougall, IC.; Tsakiris, D.; et al.
Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N.
Engl. J. Med.
16
, 2071-‐2084 (2006).
12. Rattanasompattikul, M.; Molnar, MZ.; Zaritsky, JJ.; Hatamizadeh, P.; Jing, J.; Norris, KC.; et al.
Association of malnutrition-‐inflammation complex and responsiveness to erythropoiesis-‐
stimulating agents in long-‐term hemodialysis patients. Nephrol. Dial. Transplant.
28
,1936-‐
45 (2013).
13. Barany,P.; Inflammation, serum C-‐reactive protein, and erythropoietin resistance. Nephrol.
Dial. Transplant.
16
, 224-‐227 (2001).
14. Hodges, VM.; Rainey, S.; Lappin, TR.; Maxwell, AP.; Pathophysiology of anemia and
erythrocytosis. Crit. Rev. Oncol. Hematol.
64
,139-‐158 (2007).
15. Cooper, AC.; Mikhail, A.; Lethbridge, MW.; Kemeny, DM.; Macdougall, IC.;Increased
expression of erythropoiesis inhibiting cytokines (IFN-‐gamma, TNF-‐alpha, IL-‐10, and IL-‐
13) by T cells in patients exhibiting a poor response to erythropoietin therapy. J. Am. Soc.
Nephrol.
14
, 1776-‐1784 (2003).
16. Macdougall, IC.; Cooper, AC.;Hyporesponsiveness to erythropoietic therapy due to chronic
inflammation. Eur. J. Clin. Invest.
35
, 32-‐35(2005).
17. Perez, GR.; Gonzalez, PE.; Ceballos, F.; Escallada, CR.; Gomez-‐Reino, MI., Martin-‐Rabadan, P.;
et al. [Guidelines for quality management of dialysis solutions]. Nefrologia.
24
Suppl 2, 1-‐
42 (2004).
18. Rattanasompattikul, M.; Feroze, U.; Molnar, MZ.; Dukkipati, R.; Kovesdy, CP., Nissenson,
AR.; et al. Charlson comorbidity score is a strong predictor of mortality in hemodialysis
patients. Int. Urol. Nephrol.
44
, 1813-‐1823 (2012).
19. Gunnell, J.; Yeun, JY.; Depner, TA.; Kaysen, GA.; Acute-‐phase response predicts
erythropoietin resistance in hemodialysis and peritoneal dialysis patients. Am. J. Kidney.
Dis.
33
, 63-‐72(1999).
20. Kalantar-‐Zadeh, K.; Kopple, JD.; Block, G.; Humphreys, MH.; A malnutrition-‐inflammation
score is correlated with morbidity and mortality in maintenance hemodialysis patients.
Am. J. Kidney Dis.
38
, 1251-‐1263(2001).
21. Kalantar-‐Zadeh, K.; Kopple, JD.; Humphreys, MH.; Block, G.; Comparing outcome
predictability of markers of malnutrition-‐inflammation complex syndrome in
haemodialysis patients. Nephrol. Dial. Transplant.
19
, 1507-‐19 (2004).
22. Demir, M.; Kucuk, A., Sezer, MT.; Altuntas, A., Kaya, S.; Malnutrition-‐inflammation score and
endothelial dysfunction in hemodialysis patients. J. Ren. Nutr.
20
, 377-‐383 (2010).
23. Rambod, M.; Bross, R.; Zitterkoph, J.; Benner, D.; Pithia, J.; Colman, S.; et al. Association of
Malnutrition-‐Inflammation Score with quality of life and mortality in hemodialysis
patients: a 5-‐year prospective cohort study. Am. J. Kidney Dis.
53
, 298-‐309 (2009).
